𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Loss of abh antigen expression in bladder cancer is not caused by loss of heterozygosity of the ABO locus

✍ Scribed by Peter Meldgaard; Philip H. Johnson; Niels C. Langkilde; Hans Wolf; Torben F. Ørntoft

Publisher
John Wiley and Sons
Year
1995
Tongue
French
Weight
486 KB
Volume
63
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The significance of loss of heterozygosity (LOH) of chromosome 9 as an early event in human bladder tumors has been demonstrated by several studies. We have studied LOH of the ABO gene locus at 9q34.2 by means of polymerase chain reaction (PCR) genotyping of tumor preparations and leukocytes. Twenty‐two tumors, all of which were immunohistochemically negative for ABH antigens, were examined. Eleven tumors were from blood‐group O individuals, and were examined by denaturing gradient gel electrophoresis (DGGE). They showed normal band patterns with no sign of single base mutations or LOH. All 11 A and B tumors were sorted on a fluorescence‐activated cell sorter (FACS) according to DNA content, thereby making it possible to study differences in genotype between subpopulations of cells in the same tumor. In 2 genotypically AO cases, we found 2 aneuploid subpopulations. In both cases, the most abnormal, with the highest DNA content, showed complete loss of the O allele, leaving the A allele intact. As all tumors were ABH antigen‐negative, this study demonstrates that LOH of the ABO locus on chromosome 9q34 is not the cause of loss of blood‐group ABH expression in human bladder cancer.

📜 SIMILAR VOLUMES

Coordinated downregulation of the antige
Coordinated downregulation of the antigen presentation machinery and HLA class I/β2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer
✍ Jose María Romero; Pilar Jiménez; Teresa Cabrera; José Manuel Cózar; Susana Pedr 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 327 KB 👁 1 views

Downregulation of MHC class I expression is a widespread phenomenon used by tumor cells to escape antitumor T-cell-mediated immune responses. These alterations may play a role in the clinical course of the disease. The aim of our study was to investigate the molecular mechanism underlying the absenc

Loss of heterozygosity proximal to the M
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapy
✍ Jan Dominik Kuhlmann; Heidi Schwarzenbach; Friedrich Otterbach; Martin Heubner; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

## Abstract Disseminated tumor cells (DTC) in the bone marrow (BM) are present in about 35% of ovarian cancers before surgery and after chemotherapy and are associated with worse prognosis. A molecular biomarker in the primary tumor predicting tumor cell spread would be highly desirable. The purpos

High cell kinetics is associated with am
High cell kinetics is associated with amplification of the int-2, bcl-1, myc and erbB-2 proto-oncogenes and loss of heterozygosity at the DF3 locus in primary breast cancers
✍ Alma Contegiacomo; Claudia Pizzi; Laura De Marchis; Maurizio Alimandi; Paolo Del 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 773 KB

Cell kinetics, is a predictive parameter of breast-cancer aggressiveness, and mutations occurring in mammary tumorigenesis may favor iuncontrolled cell proliferation. In this study, cell kinetics, clinico-pathological characteristics and genetic alterations at the irrt-2, bcl-I, c-myc, c-erbB-2, and